Access to cancer treatment in Uganda remains a challenge, with only a handful of cancer institutions spread across the ...

TissueCypher is a laboratory test that can help predict the risk of developing esophageal cancer in patients diagnosed with Barrett’s esophagus (BE).

In recent years, there has been a concerning trend of increasing cases of colorectal and other gastrointestinal (GI) cancers ...

Half of all cancer deaths worldwide are attributable to modifiable risk factors, according to The Cancer Atlas.

A capsule-sponge test may help identify patients with Barrett’s esophagus who are at low risk for dysplasia or esophageal ...

Esophageal cancer is emerging as an increasingly serious health concern in Rwanda, with new cases persistently rising over the past five years. According to data from the Rwanda Biomedical Center (RBC ...

Further data could back zanidatamab as advanced treatment for HER2-positive advanced gastroesophageal adenocarcinoma.

Bemarituzumab targets FGFR2b, which has been found to be overexpressed in approximately 30% of patients with non-HER2 positive gastric cancer.

A test developed by a Madison company to better track cancer DNA in the blood stream will now be covered by Medicare.

The community is rallying to support a Scenic Rim school bus driver after he was diagnosed with terminal cancer.

This year, more than 22,000 Americans face a chilling diagnosis — esophageal cancer. A new 3-minute in-office test is ...

Discover the new EsoGuard test, touted as a non-invasive method for early detection of esophageal cancer that offers hope for ...